Malte Peters

Malte Peters

Chief Executive Officer at TANGO THERAPEUTICS, INC.

Net worth: 255 600 $ as of 31/10/2026

63 year
Health Technology
Consumer Services

Profile

Malte Peters currently serves as President, Chief Executive Officer & Director at Tango Therapeutics, Inc. since 2026.
Also holds positions as Director at Tango Therapeutics Sub, Inc. since 2018, Director-Cancer Research at Merck KGAA Unsponsored ADR Facility, and Research Scientist at Amgen NV.
Former roles include Chief Executive Officer & Director at Hookipa Biotech AG in 2024, Chief Executive Officer & Director at HOOKIPA Pharma, Inc. from 2023 to 2026, Director-Cancer Research at Merck KGaA from 2003 to 2004, Medical Director at Micromet AG from 2003 to 2004, Head-Clinical, Site Head-Basel & East Hanover at Novartis AG from 2004 to 2015, Chief Research & Development Officer at MorphoSys AG from 2020 to 2022, and Global Head-Clinical Development at Sandoz International GmbH from 2015 to 2017.
Education includes a doctorate from Freie Universität Berlin.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/04/2026 11,250 ( 0.01% ) 255 600 $ 31/10/2026

Malte Peters active positions

CompaniesPositionStart
TANGO THERAPEUTICS, INC. Chief Executive Officer 08/01/2026
Director/Board Member 10/10/2018
Corporate Officer/Principal -
Merck KGAA Unsponsored ADR Facility
Corporate Officer/Principal -

Former positions of Malte Peters

CompaniesPositionEnd
HOOA PHARPAR Chief Executive Officer 01/07/2026
Chief Executive Officer 18/11/2024
MORPHOSYS AG Chief Tech/Sci/R&D Officer 01/10/2022
Corporate Officer/Principal 01/02/2017
NOVARTIS AG Chief Tech/Sci/R&D Officer 01/05/2015
See the detail of Malte Peters's experience

Education of Malte Peters

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

81

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Merck KGAA Unsponsored ADR Facility

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology